Short-term suppression of plasma free fatty acids fails to improve insulin sensitivity when intramyocellular lipid is elevated

Diabetic Medicine

Volumn 23, Issue 10, 2006, Pages 1061-1068

  Johnson, N A ^a   Stannard, S R ^b   Rowlands, D S ^b   Chapman, P G ^a   Thompson, C H ^c   Sachinwalla, T ^d   Thompson, M W ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MASSEY UNIVERSITY   (New Zealand)

^c FLINDERS UNIVERSITY   (Australia)

^d Rayscan Imaging   (Australia)

Author keywords

Glucose tolerance; High fat dietl insulin resistance; Intramuscular triglyceride

Indexed keywords

CARBOHYDRATE; FATTY ACID; LIPID; NICOTINIC ACID;

ADULT; ARTICLE; CARBOHYDRATE DIET; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPID DIET; MALE; NORMAL HUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; TISSUE LEVEL; VASTUS LATERALIS MUSCLE;

ADULT; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIET; DIETARY FATS; FATTY ACIDS, NONESTERIFIED; HUMANS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MALE; TRIGLYCERIDES;

EID: 33748744514     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2006.01952.x     Document Type: Article

References (44)

1. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997; 46: 3-10.
2. Sparti A, Decombaz J. Effect of diet on glucose tolerance 36 hours after glycogen-depleting exercise. Eur J Clin Nutr 1992; 46: 377-385.
3. Bisschop PH, de Metz J, Ackermans MT, Endert E, Pijl H, Kuipers F et al. Dietary fat content alters insulin-mediated glucose metabolism in healthy men. Am J Clin Nutr 2001; 73: 554-559.
4. Bachmann OP, Dahl DB, Brechtel K, Machann J, Haap M, Maier T et al. Effects of intravenous and dietary lipid challenge on intramyo-cellular lipid content and the relation with insulin sensitivity in humans. Diabetes 2001; 50: 2579-2584.
5. Boden G, Lebed B, Schatz M, Homko C, Lemieux S. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 2001; 50: 1612-1617.
6. Dresner A, Laurent D, Marcucci ME, Griffin M, Dufour S, Cline GW et al. Effects of free fatty acids on glucose transport and IRS-1-associated phospatidylinositol 3-kinase activity. J Clin Invest 1999; 103: 253-259.
7. Griffin ME, Marcucci ME, Cline GW, Bell K, Barucci N, Lee D et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase theta and alterations in the insulin signaling cascade. Diabetes 1999; 48: 1270-1274.
8. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C and IκB-α. Diabetes 2002; 51: 2005-2011.
9. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996; 97: 2859-2865.
10. Kashyap SR, Belfort R, Berria R, Suraamornkul S, Pratipranawatr T, Finlayson J et al. Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes. Am J Physiol - Endocrinol Metab 2004; 287: E537-546.
11. Santomauro AT, Boden G, Silva ME, Rocha DM, Santos RF, Ursich MJ et al. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 1999; 48: 1836-1841.
12. Ahren B. Reducing plasma free fatty acids by acipimox improves glucose tolerance in high-fat fed mice. Acta Physiol Scand 2001; 171: 161-167.
13. Bajaj M, Suraamornkul S, Romanelli A, Cline GW, Mandarino LJ, Shulman GI et al. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty acyl-CoAs and insulin action in type 2 diabetic patients. Diabetes 2005; 54: 3148-3153.
14. DeFronzo RA, Gunnearsson R, Bjorkman O, Olsson M, Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependant (Type II) diabetes mellitus. J Clin Invest 1985; 76: 149-155.
15. Decombaz J, Schmitt B, Ith M, Decarli B, Diem P, Kreis R et al. Postexercise fat intake repletes intramyocellular lipids but no faster in trained than in sedentary subjects. Am J Physiol - Regul Integr Comp76 Physiol 2001; 281: R760-9.
16. Goodpaster BH, He J, Watkins S, Kelley DE. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 2001; 86: 5755-5761.
17. Jacob S, Machann J, Rett K, Brechtel K, Volk A, Renn W et al. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 1999; 48: 1113-1119.
18. Greco AV, Mingrone G, Giancaterini A, Manco M, Morroni M, Cinti S et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 2002; 51: 144-151.
19. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 1: 785-789.
20. Ellis BA, Poynten A, Lowy AJ, Furler SM, Chisholm DJ, Kraegen EW et al. Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am J Physiol 2000; 279: E554-E560.
21. Schmitz-Peiffer C, Craig D, Biden T. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 1999; 274: 24202-24210.
22. Hegarty BD, Furler SM, Yee AJ, Cooney GJ, Kraegen EW. The role of intramuscular lipid in insulin resistance. Acta Physiol Scand 2003; 178: 373-383.
23. Ikeda T, Terasawa H, Ishimura M, Ochi H, Noguchi I, Fujiyama K et al. Inhibitory effect of fatty acids on glucose and insulin uptake in the perfused rat hindquarter. Biochem Med Metabolic Biol 1994; 52: 97-100.
24. Walker M, Fulcher GR, Catalano C, Petranyi G, Orskov H, Alberti KG. Physiological levels of plasma non-esterified fatty acids impair forearm glucose uptake in normal man. Clin Sci 1990; 79: 167-174.
25. Brozek J, Grande F, Anderson JT, Keys A. Densiometric analysis of body composition: revision of some quantitative assumptions. Ann NY Acad Sci 1963; 110: 113-140.
26. Goldman HI, Becklake MR. Respiratory function tests: Normal values at medium altitudes and the prediction of normal results. Am Rev Tuberc 1959; 79: 457-467.
27. NHMRC. National Health and Medical Research Council: Dietary guidelines for Australian adults. In http://www.nhmrc.gov.au/publications/synopses/dietsyn. htm 2003. Last accessed 3 May 2005.
28. Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK et al. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 1999; 276: E977-989.
29. Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R et al. Java-based graphical user interface for the MRUI quantitation package. Magma 2001; 12: 141-152.
30. Johnson NA, Stannard SR, Mehalski K, Trenell MI, Sachinwalla T, Thompson CH et al. Intramyocellular triacylglycerol in prolonged cycling with high- and low-carbohydrate availability. J Appl Physiol 2003; 94: 1365-1372.
31. Pacini G, Bergman RN. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Computer Meth Programs Biomed 1986; 23: 113-122.
32. Krebs M, Krssak M, Nowotny P, Weghuber D, Gruber S, Mlynarik V et al. Free fatty acids inhibit the glucose-stimulated increase of intramuscular glucose-6-phosphate concentration in humans. J Clin Endocrinol Metab 2001; 86: 2153-2160.
33. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 2002; 277: 50230-50236.
34. Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, Goto T, Westerbacka J, Sovijarvi A et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002; 87: 3023-3028.
35. Kim JK, Fillmore JJ, Sunshine MJ, Albrecht B, Higashimori T, Kim DW et al. PKC-theta knockout mice are protected from fat-induced insulin resistance. J Clin Invest 2004; 114: 823-827.
36. Kim JK, Gimeno RE, Higashimori T, Kim HJ, Choi H, Punreddy S et al. Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. J Clin Invest 2004; 113: 756-763.
37. Horowitz M, Edelbroek MA, Wishart JM, Straathof JW. Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia 1993; 36: 857-862.
38. Anderson RL, Hamman RF, Savage PJ, Saad MF, Laws A, Kades WW et al. Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance (FSIGT) tests. The Insulin Resistance Atherosclerosis Study. Am J Epidemiol 1995; 142: 724-732.
39. Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 1987; 79: 790-800.
40. Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen YD et al. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study. Diabetes 1994; 43: 1114-1121.
41. Schenk S, Cook JN, Kaufman AE, Horowitz JF. Postexercise insulin sensitivity is not impaired after an overnight lipid infusion. Am J Physiol - Endocrinol Metab 2005; 288: E519-525.
42. Galvin P, Ward G, Walters J, Pestell R, Koschmann M, Vaag A et al. A simple method for quantitation of insulin sensitivity and insulin release from an intravenous glucose tolerance test. Diabet Med 1992; 9: 921-928.
43. Wang W, Basinger A, Neese RA, Christiansen M, Hellerstein MK. Effects of nicotinic acid on fatty acid kinetics, fuel selection, and pathways of glucose production in women. Am J Physiol - Endocrinol Metab 2000; 279: E50-59.
44. Hovorka R, Shojaee-Moradie F, Carroll PV, Chassin LJ, Gowrie IJ, Jackson NC et al. Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT. Am J Physiol - Endocrinol Metab 2002; 282: E992-1007.